Abstract: Molecules or salts thereof are provided, having the structure in Formula I, wherein n2 and n4 are the same or different and are independently 1, 2, or 3, and n3 is 1 to 20; X is oxygen, nitrogen, or sulfur; wherein R1, R2, R3, R4, R5, R6, and R7 are as described herein. Methods are also provided for the synthesis of and use of the provided molecules in applications for diagnostic testing.

Abstract: Molecules or salts thereof are provided, having the structure in Formula I, wherein n2 and n4 are the same or different and are independently 1, 2, or 3, and n3 is 1 to 20; X is oxygen, nitrogen, or sulfur; wherein R1, R2, R3, R4, R5, R6, and R7 are as described herein. Methods are also provided for the synthesis of and use of the provided molecules in applications for diagnostic testing.

Abstract: Molecules compounds are provided having the structure in Formula I, or a salt thereof, wherein n1 is independently 0, 1, 2, or 3; n2 is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20; n3 is from 0, 1, 2, or 3; n4 is 0 or 1; and n5 is 0, 1, 2, or 3; and wherein X is O, N, or S; Y, Z, XX, and YY are the same or different and are independently O or S; ZZ comprises nitrogen, oxygen, sulfur, or selenium; and wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 are as described herein. Methods are also provided for the synthesis of and use of the provided molecules in applications for diagnostic testing.

Abstract: Molecules or salts thereof are provided, having the structure in Formula I, wherein n2 and n are the same or different and are independently 1, 2, or 3, and n is 1 to 20; X is oxygen, nitrogen, or sulfur; wherein R1, R2, R3, R4, R5, R6, and R7 are as described herein. Methods are also provided for the synthesis of and use of the provided molecules in applications for diagnostic testing.

Abstract: Provided are methods and compositions for providing early cell therapy options to subjects, offering the potential benefit of avoiding higher risk treatment modalities.

Abstract: The invention provides lubricant compositions comprising magnesium stearate dihydrate. The lubricant compositions may be used to lubricate a variety of solid materials that are used in industrial or consumer products.

Abstract: The invention provides lubricant compositions comprising magnesium stearate dihydrate. The lubricant compositions may be used to lubricate a variety of bioactive formulations including pharmaceutical compositions.

Abstract: The present invention relates generally to the field of behavior sensing and recording device. More specifically, the present invention is to measure and record full motion related signals on a part of putter. A miniaturized data logging device for golf putters that records outputs from motion sensors during whole game is described. Utilizing accelerometers, the device obtains relative motion invoked at a putter head without affecting player's performance. The device also records such information for multiple incidents or for an indefinite period of time. The device will be attached on the surface of a putter head at which motion behavior analysis takes place. The present invention uses high density memory chip and USB for data transfer. The flash multi media storage card is also used for transferring the recorded data to personal computing devices such as personal computer, personal digital assistant (PDA), or a plurality of mobile devices.

Abstract: Semiconductor devices formed on wafers are inspected using a master wafer. A subject wafer of a semiconductor design is provided. The subject wafer has dies wherein semiconductor devices of the semiconductor design are formed and at a stage of fabrication. A current layer of the subject wafer is scanned to obtain a scanned layer/image. A master wafer comprising individual wafer/layer maps is obtained. The scanned layer is compared with a corresponding layer map. Matching and non-matching defects are identified from repetitive defects within the corresponding layer map and defects within the scanned layer. The matching defects are reviewed to classify and or identify causality. The master wafer is then updated.

Abstract: A lightweight intermediary aggregate for producing lightweight aggregate construction material is disclosed, in which expanded plastic beads are coated with an adhesive mixture comprising 50 to 100% viscous soil, 0 to 50% Portland cement, 0 to 6% sand, 0 to 10% calcium hydroxide, 0 to 4% sodium silicate together with an appropriate amount of water to form an intermediary layer. The lightweight intermediary aggregate is then fired to form the lightweight aggregate or cement mortar is additionally coated as an outer coating over the intermediary layer and cured.